Locomotor behavioral effects of prenatal and postnatal nicotine exposure in rat offspring

被引:46
作者
Newman, MB
Shytle, RD
Sanberg, PR
机构
[1] Univ S Florida, Coll Arts & Sci, Dept Neurosurg, Tampa, FL 33612 USA
[2] Univ S Florida, Coll Arts & Sci, Dept Psychol, Tampa, FL 33612 USA
[3] Univ S Florida, Coll Arts & Sci, Neurosci Program, Tampa, FL 33612 USA
[4] Univ S Florida, Coll Med, Tampa, FL 33612 USA
来源
BEHAVIOURAL PHARMACOLOGY | 1999年 / 10卷 / 6-7期
关键词
nicotine; hyperactivity; ADHD; nACHr; prenatal; postnatal; rat;
D O I
10.1097/00008877-199911000-00017
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The purpose of this study was to determine if prenatal/postnatal nicotine exposure results in hyperactive offspring. Rat offspring were exposed to nicotine, through implantation of osmotic minipumps in dams, at levels of 0.75, 1.5 and 3.0 mg/kg/day, for 19 days prenatally and 16 days postnatally. Offspring were measured for gestation length, body weight, litter size, sex difference and locomotor activity. No significant effects were shown for gestation length, litter size or male to female pup ratio. However, higher percentage of pup deaths resulted from nicotine-exposed dams than from control dams. Significantly less litter body weight was shown in nicotine-exposed offspring on postnatal day 1 when compared to controls. However, these offspring surpassed the control groups in litter body weight on postnatal day 14 and 21. Hyperactivity was shown in offspring exposed to prenatal/postnatal nicotine at levels of 0.75 and 3.0 mg/kg/day on postnatal day 14, but not on postnatal day 21 or at the 1.5 mg/kg/day condition. Results are consistent with the hypothesis that rat offspring are susceptible to the neurochemical and neurobehavioral effects of prenatal/postnatal nicotine exposure. (C) 1999 Lippincott Williams & Wilkins.
引用
收藏
页码:699 / 706
页数:8
相关论文
共 36 条
[1]  
[Anonymous], 1996, Diagnostic and statistical manual of mental disorders
[2]   THE EFFECTS OF NICOTINE ON BRAIN NEUROTRANSMITTER SYSTEMS [J].
BALFOUR, DJK .
PHARMACOLOGY & THERAPEUTICS, 1982, 16 (02) :269-282
[3]   Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders [J].
Balfour, DJK ;
Fagerstrom, KO .
PHARMACOLOGY & THERAPEUTICS, 1996, 72 (01) :51-81
[4]   DESENSITIZATION OF THE NICOTINE-INDUCED MESOLIMBIC DOPAMINE RESPONSES DURING CONSTANT INFUSION WITH NICOTINE [J].
BENWELL, MEM ;
BALFOUR, DJK ;
BIRRELL, CE .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (02) :454-460
[5]  
BENWELL MEM, 1994, CLIN INVESTIGATOR, V72, P233
[6]   NICOTINE AND COTININE CONCENTRATIONS IN THE NURSING MOTHER AND HER INFANT [J].
DAHLSTROM, A ;
LUNDELL, B ;
CURVALL, M ;
THAPPER, L .
ACTA PAEDIATRICA SCANDINAVICA, 1990, 79 (02) :142-147
[7]   HYPERKINESIS AND MATERNAL SMOKING [J].
DENSON, R ;
NANSON, JL ;
MCWATTERS, MA .
CANADIAN PSYCHIATRIC ASSOCIATION JOURNAL, 1975, 20 (03) :183-187
[8]  
DUNN HG, 1977, CAN J PUBLIC HEALTH, V68, P43
[9]   NICOTINE CONCENTRATIONS IN URINE AND SALIVA OF SMOKERS AND NONSMOKERS [J].
FEYERABEND, C ;
HIGENBOTTAM, T ;
RUSSELL, MAH .
BRITISH MEDICAL JOURNAL, 1982, 284 (6321) :1002-1004
[10]   SMOKING - HEALTH-EFFECTS AND CONTROL .1. [J].
FIELDING, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (08) :491-498